BRIEF published on 01/21/2025 at 07:03, 2 months 23 days ago DocMorris annonce une croissance de 6,7 % en 2024 avec une forte augmentation des revenus des médicaments sur ordonnance Résultats Financiers 2024 Croissance De DocMorris Augmentation Des Revenus Des Médicaments Sur Ordonnance Performances De La TéléClinique Tendances Du Marché Allemand
PRESS RELEASE published on 01/21/2025 at 06:58, 2 months 23 days ago DocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter DocMorris grows 6.7% in 2024 with increased Rx sales, OTC revenues and TeleClinic profits. Achieved revenue target and positive cash position. Outlook confirmed for 2024 Revenue Growth DocMorris Rx Sales TeleClinic OTC Revenues
BRIEF published on 10/15/2024 at 07:03, 5 months 29 days ago DocMorris accélère la croissance des médicaments sur ordonnance Croissance Des Revenus Télésanté DocMorris AG Médicaments Sur Ordonnance Fermeture Logistique
BRIEF published on 10/15/2024 at 07:03, 5 months 29 days ago DocMorris Accelerates Prescription Medicine Growth Revenue Growth Telehealth DocMorris AG Prescription Medicine Logistics Closure
PRESS RELEASE published on 10/15/2024 at 06:58, 5 months 29 days ago DocMorris accelerates Rx growth DocMorris accelerates Rx growth with a 12.2% revenue increase in Q3, new CTO appointed, and logistics site closure in Germany. Strong growth in e-prescriptions and customer base E-prescriptions DocMorris CTO Appointment Rx Growth Logistics Site Closure
BRIEF published on 08/20/2024 at 07:03, 7 months 24 days ago DocMorris améliore son activité de prescription et stimule les investissements de ses nouveaux clients en matière de prescription Perspectives 2024 Ordonnances Électroniques Doc Morris Entreprise De Prescription TéléClinique
BRIEF published on 08/20/2024 at 07:03, 7 months 24 days ago DocMorris Enhances Prescription Business and Boosts New Rx Customer Investment 2024 Outlook E-prescriptions DocMorris Prescription Business TeleClinic
PRESS RELEASE published on 08/20/2024 at 06:58, 7 months 24 days ago DocMorris grows in the prescription business and invests incrementally in new Rx customers DocMorris reports growth in prescription business and increased investments in new Rx customers. Break-even reached, outlook for 2024 adjusted due to e-prescription transition Financial Results E-prescriptions New Customers DocMorris Prescription Business
BRIEF published on 07/11/2024 at 07:03, 9 months 2 days ago DocMorris Reports Significant eRx Growth in Q2 2024 Revenue Increase Market Expansion DocMorris ERx Growth
BRIEF published on 07/11/2024 at 07:03, 9 months 2 days ago DocMorris annonce une croissance significative d'eRx au deuxième trimestre 2024 L'expansion Du Marché Augmentation Des Revenus DocMorris Croissance ERx
Published on 04/12/2025 at 15:45, 1 day 1 hour ago New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 15 hours ago Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 17 hours ago Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/11/2025 at 23:45, 1 day 17 hours ago Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties
Published on 04/11/2025 at 21:45, 1 day 19 hours ago OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:38, 1 day 22 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 1 day 22 hours ago EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:30, 1 day 22 hours ago Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 1 day 22 hours ago Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 1 day 23 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 1 day 23 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 1 day 23 hours ago Mise à disposition du Rapport Financier Annuel 2024
